Just What is Oncotarget, and Why All the Buzz?

Oncotarget is the world’s only semiweekly medical journal wherein doctors, researchers, and laymen share their latest arsenal of information to help cancer patients, and to help defeat this devastating illness.

Although the journal accepts articles on other medical subjects, its heaviest and most outstanding focus is directed at oncology, the study of cancer and its possible treatments and cures. Learn more about Oncotarget at Research Gate.

Published twice per week, Oncotarget is one of the top published journals in medical professions, and has been published since 2010. The editors are Mikhail Blagosklonny and Andrei V. Gudkov (Roswell Park Cancer Institute).

Because of its semiweekly publishing methods, Oncotarget (published by Impact Publications) is likely the premier introduction of a myriad of new thoughts, ideas, and treatments as they relate to oncology and other medical ills. Due to its immediacy and international scope, many researchers and doctors refer to the semiweekly journals on a regular basis in researching treatments and techniques as they relate to their patients and studies. Check Oncotarget journal at scimagojr.com

Abstracted and indexed by a number of indices and publications, Oncotarget has become and remains one of the most regularly influential publications in the genre of medicine and cancer research.

Oncotarget has had an impact on the study and treatment of other diseases and treatments as well. Almost any article that can be of value to researchers and doctors treating difficult diseases can be found in the journal, and it has been very helpful in many aspects of their research.

It is possibly the most influential and useful journals for medical professionals today. New therapies have been researched and shared about thyroid cancers in particular, with their studies being published and shared in the journal. Researchers are touting the new methods described and presented in the journal as life-savers. Oncotarget has proven to be a boon to the medical field.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/